Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

MANERIX

BAUSCH HEALTH, CANADA INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MANERIX discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MANERIX 300MG has been permanently discontinued (last updated January 8, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is MANERIX not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file1 product
Affected strength300MG
Report last updated2025-01-08
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MOCLOBEMIDE

AA PHARMA INC

300MG · DIN 02240456

Same strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02166747

Strength

300MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

MOCLOBEMIDE

Tier

Unrated

Last Updated

2025-01-08

Reason for Shortage

Business reasons

Other Products from BAUSCH HEALTH, CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.